Aileen Ebenig
5PUBLICATIONS
39CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (5)
Sort by Publication Date:
|Mar 18, 2025
Differential efficacy of first licensed western vaccines protecting without immunopathogenesis Wuhan-1-challenged hamsters from severe COVID-19.Aileen Ebenig, Mona V Lange, Michelle Gellhorn Serra
|May 30, 2024
TMPRSS2-mediated SARS-CoV-2 uptake boosts innate immune activation, enhances cytopathology, and drives convergent virus evolution.Bingqian Qu, Csaba Miskey, André Gömer
|Apr 03, 2023
Live-attenuated vaccine sCPD9 elicits superior mucosal and systemic immunity to SARS-CoV-2 variants in hamsters.Geraldine Nouailles, Julia M Adler, Peter Pennitz
|Oct 15, 2022
Versatility of live-attenuated measles viruses as platform technology for recombinant vaccines.Aileen Ebenig, Mona V Lange, Michael D Mühlebach
|Dec 01, 2020
A highly immunogenic and effective measles virus-based Th1-biased COVID-19 vaccine.Cindy Hörner, Christoph Schürmann, Arne Auste
Pageof 1
Frequent Collaborators
5 joint publications
Michael D Mühlebach
2 joint publications
Christoph Schürmann
2 joint publications
Maike Herrmann
2 joint publications
Barbara S Schnierle
2 joint publications
Mona V Lange
2 joint publications
Christine Goffinet
1 joint publications
Cindy Hörner
1 joint publications
Arne Auste
1 joint publications
Samada Muraleedharan
1 joint publications
Kenneth H Dinnon
